Skip to main content

Advertisement

Log in

The overturn of Roe v. Wade beyond abortion: a snapshot of methotrexate accessibility for people with rheumatic and musculoskeletal diseases—a mixed methods study using Twitter data

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

In June 2022, the Supreme Court of the United States (US) overturned the right established in Roe v. Wade to terminate a pregnancy. Subsequently, some states passed abortion ban laws prohibiting the use of abortive methods, including methotrexate (MTX), which has been a cornerstone drug in rheumatology. We aimed to explore and analyze Twitter data to comprehend the short-term implications of the overturn on rheumatology care. We conducted a mixed methods study using social media (SoMe) data. Tweets publicly posted using “#Methotrexate or Methotrexate” were tracked. A combination of SoMe performance data with qualitative hashtag co-occurrence analysis and content analysis was conducted. A total of 5180 posts were generated and reached approximately 40 million users. Seventy-three percent of all publications came from the US. Females posted more than males. Additionally, the three pairs of hashtags with higher co-occurrence were: #roevswade, #abortionishealthcare, and #rheumatoidarthritis. From the content analysis, three main themes were generated: (i) violence against women, (ii) health policy without public health intelligence, and (iii) call for strategic alliances in favor of public health. The combination of biological sex and state of residence could condition the use of MTX. Men will be able to continue their treatment; however, women could lose continuity of it. Inequity in access to treatment is a political decision, just as it is to reproduce inequities and vulnerabilities through the actions taken. Not having access to MTX for rheumatic and musculoskeletal diseases (RMDs) is a critical issue that endangers the physical and mental health of people with RMDs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The secondary data used in this study are public, published by users with public accounts on the SoMe platform Twitter (http://www.twitter.com).

References

  1. Wade R (1973) 410 US 113

  2. Press, T.A. (2022) Abortion ruling prompts variety of reactions from states. The Associated Press

  3. Zhang J et al (2022) Medical methods for first trimester abortion. Cochrane Database Syst Rev 5(5):Cd0028555

  4. Chan ES, Cronstein BN (2010) Methotrexate—how does it really work? Nat Rev Rheumatol 6(3):175–178

    Article  CAS  PubMed  Google Scholar 

  5. Jukes T (1978) The history of methotrexate. Cutis 21(3):396–398

    CAS  PubMed  Google Scholar 

  6. Aickara D et al (2022) Topical methotrexate in dermatology: a review of the literature. J Dermatol Treat 33(1):512–517

    Article  Google Scholar 

  7. García-González CM, Baker J (2022) Treatment of early rheumatoid arthritis: methotrexate and beyond. Curr Opin Pharmacol 64:102227

    Article  PubMed  Google Scholar 

  8. Johnson CM, Dassopoulos T (2018) Update on the use of thiopurines and methotrexate in inflammatory bowel disease. Curr Gastroenterol Rep 20(11):1–8

    Article  CAS  Google Scholar 

  9. Chung SA et al (2021) 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheumatol 73(8):1366–1383

    Article  CAS  PubMed  Google Scholar 

  10. Hahn BH et al (2012) American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 64(6):797–808

    Article  Google Scholar 

  11. Fraenkel L et al (2021) 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 73(7):1108–1123

    Article  PubMed  Google Scholar 

  12. Singh JA et al (2019) 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol 71(1):5–32

    Article  PubMed  Google Scholar 

  13. Giollo A, Fuzzi E, Doria A (2022) Methotrexate in early rheumatoid arthritis: is the anchor drug still holding? Autoimmun Rev 21(4):103031

    Article  CAS  PubMed  Google Scholar 

  14. Rheumatology TL (2022) The demise of Roe v Wade: ramifications for rheumatology. Lancet Rheumatol 4(8):e525. https://doi.org/10.1016/S2665-9913(22)00189-8

  15. Negrón JB (2019) # EULAR2018: the annual European congress of rheumatology—a twitter hashtag analysis. Rheumatol Int 39(5):893–899

    Article  PubMed  Google Scholar 

  16. Mcneill A, Burke S (2021) Social media data. In: Lyons E, Coyle A (eds) Analysing qualitative data in psychology. SAGE, pp 83–99

  17. Wang R, Liu W, Gao S (2016) Hashtags and information virality in networked social movement: examining hashtag co-occurrence patterns. Online Inf Rev 40(7):850–866

  18. Simpson E (2018) Integrated & alone: The use of hashtags in Twitter social activism. In: Companion of the 2018 ACM conference on computer supported cooperative work and social computing

  19. Brown ME, Dueñas AN (2020) A medical science educator’s guide to selecting a research paradigm: building a basis for better research. Med Sci Educator 30(1):545–553

    Article  Google Scholar 

  20. Quan-Haase A, Sloan L (2017) Introduction to the handbook of social media research methods: goals, challenges and innovations. In: Quan-Haase A, Sloan L (eds) The SAGE handbook of social media research methods. SAGE, pp 1–9

  21. Ferrara E et al (2016) The rise of social bots. Commun ACM 59(7):96–104

    Article  Google Scholar 

  22. Himelein-Wachowiak M et al (2021) Bots and misinformation spread on social media: implications for COVID-19. J Med Internet Res 23(5):e26933

    Article  PubMed  PubMed Central  Google Scholar 

  23. Pozzana I, Ferrara E (2020) Measuring bot and human behavioral dynamics. Front Phys:125

  24. Flick U (2014) Thematic coding and content analysis. In: SAGE (ed) An introduction to qualitative research. SAGE, pp 420–438

  25. Saldaña J (2021) The coding manual for qualitative researchers. SAGE. pp 1–440

  26. Bermas BL (2022) The unintended consequence of the overturn of Roe v Wade: restrictions on methotrexate use. J Rheumatol 49(11):1284–1285

    Article  PubMed  Google Scholar 

  27. Dean B (2022) How many people use Twitter in 2022? [New Twitter Stats]

  28. Cohen SB et al (2022) Impact of methotrexate discontinuation, interruption, or persistence in US patients with rheumatoid arthritis initiating tofacitinib + oral methotrexate combination. Clin Ther 44(7):982–997

  29. Xu J et al (2022) Methotrexate use reduces mortality risk in rheumatoid arthritis: a systematic review and meta-analysis of cohort studies. Semin Arthritis Rheum 55:152031

  30. Arnold S et al (2022) Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors. Rheumatology 61(1):131–138

    Article  CAS  Google Scholar 

  31. Ritschl V et al (2020) Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider. RMD Open 6(3):e001432

    Article  PubMed  PubMed Central  Google Scholar 

  32. Callard F, Perego E (2021) How and why patients made long Covid. Soc Sci Med 268:113426

    Article  PubMed  PubMed Central  Google Scholar 

  33. Davis CA et al (2016) Botornot: a system to evaluate social bots. In: Proceedings of the 25th international conference companion on world wide web

  34. Institute's, T.G. Interactive map: US abortion policies and access after Roe. 2023 [cited 2023 June]. Available from: https://states.guttmacher.org/policies/

Download references

Acknowledgements

To María Piedad Rosario (medical librarian) for obtaining the full-texts to review the existing literature.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José B. Negrón.

Ethics declarations

Conflict of interest

No funding was received for the completion of this research project. However, JBN has received personal grants from the European Alliance of Associations for Rheumatology (EULAR) for activities unrelated to this work. Additionally, he is member of the Outcome Measures in Rheumatology (OMERACT). He has also worked as research fellow in the patient outcomes in longitudinal studies working group of OMERACT.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Negrón, J.B., Rodriguez-Malavé, M.J., Camacho, C.O. et al. The overturn of Roe v. Wade beyond abortion: a snapshot of methotrexate accessibility for people with rheumatic and musculoskeletal diseases—a mixed methods study using Twitter data. Rheumatol Int 43, 2293–2301 (2023). https://doi.org/10.1007/s00296-023-05407-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-023-05407-1

Keywords

Navigation